The Food and Drug Administration has granted emergency authorization to a dozen coronavirus antibody tests, and more than 200 others are currently on the market. One authorized company, Roche, claims its test is 100% accurate at finding coronavirus antibodies in the blood and 99.8% accurate at ruling them out. Many people who got sick in…
A preliminary, unpublished study speculates that vitamin D deficiency may have something to do with poor COVID-19 outcomes. Its authors suggest people may benefit from ensuring they are getting enough vitamin D. However, there are serious concerns about the research. Share on PinterestA new study wonders whether vitamin D deficiency might play a role in…
Click here if you want to submit a question about the coronavirus.Trust Index: Pulse oximeterIn the hospital, many people are put on monitors called pulse oximeters, which work by painlessly shining a special red light through the pad of your finger or your earlobe and detecting how much can be seen from the other side.The…
Click here if you want to submit a question about the coronavirus.Trust Index: Pulse oximeterIn the hospital, many people are put on monitors called pulse oximeters, which work by painlessly shining a special red light through the pad of your finger or your earlobe and detecting how much can be seen from the other side.The…
7.4M Want to watch this again later? Sign in to add this video to a playlist. Sign in Like this video? Sign in to make your opinion count. Sign in Don't like this video? Sign in to make your opinion count. Sign in Published on Apr 24, 2020Just to be clear: it is never, ever,…
3 min read This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest. ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw skin along his shoulders and spine. “My wounds take up a large percentage of
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing COVID-19 in people aged 12 years or older. The vaccine was approved in May 2025 by the US FDA for individuals aged 65 years or older or aged 12-64 years
KFF Health News chief Washington correspondent Julie Rovner discussed Affordable Care Act subsidies on Crooked Media’s What a Day on Dec. 10 and on Slate’s What Next on Dec. 9. Click here to hear Rovner on What a Day. Click here to hear Rovner on What Next. KFF Health News Washington health policy reporter Amanda